# The Individually-Marked Panretinal Laser phoTocoagulation for Proliferative Diabetic Retinopathy Study (TREAT)

> **NCT03113006** · NA · COMPLETED · sponsor: **Odense University Hospital** · enrollment: 53 (actual)

## Conditions studied

- Proliferative Diabetic Retinopathy
- PDR
- Diabetes

## Interventions

- **PROCEDURE:** Panretinal Photocoagulation

## Key facts

- **NCT ID:** NCT03113006
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-01
- **Primary completion:** 2019-08-27
- **Final completion:** 2019-08-27
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2019-08-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03113006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03113006, "The Individually-Marked Panretinal Laser phoTocoagulation for Proliferative Diabetic Retinopathy Study (TREAT)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03113006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*